Litcius/Paper detail

Proton-Sensing G Protein-Coupled Receptors: Detectors of Tumor Acidosis and Candidate Drug Targets

Paul A. Insel, Krishna Sriram, Cristina Salmerón, Shu Z. Wiley

2020Future Medicinal Chemistry23 citationsDOIOpen Access PDF

Abstract

Cells in tumor microenvironments (TMEs) use several mechanisms to sense their low pH (<7.0), including via proton-sensing G protein-coupled receptors (psGPCRs): GPR4, GPR65/TDAG8, GPR68/OGR1 and GPR132/G2A. Numerous cancers have increased expression of psGPCRs. The psGPCRs may contribute to features of the malignant phenotype via actions on specific cell-types in the TME and thereby promote tumor survival and growth. Here, we review data regarding psGPCR expression in tumors and cancer cells, impact of psGPCRs on survival in solid tumors and a bioinformatics approach to infer psGPCR expression in cell types in the TME. New tools are needed to help define contributions of psGPCRs in tumor biology and to identify potentially novel therapeutic agents for a variety of cancers.

Topics & Concepts

ReceptorDrugProtonDrug candidateDrug discoveryDetectorG protein-coupled receptorChemistryPharmacologyComputational biologyPhysicsNanotechnologyBiologyMaterials scienceBiochemistryNuclear physicsOpticsReceptor Mechanisms and SignalingCancer, Hypoxia, and MetabolismATP Synthase and ATPases Research
Proton-Sensing G Protein-Coupled Receptors: Detectors of Tumor Acidosis and Candidate Drug Targets | Litcius